Arrayit Q1 Revenues Jump 15 Percent on Microarray Instrument Sales | GenomeWeb

NEW YORK (GenomeWeb) – Arrayit today reported a 15 percent spike in first quarter sales driven by sales of microarray instruments.

Total revenues for the three months ended March 31 were $1.1 million up from $942,916 in the first quarter of 2013.

On an earnings call President Mark Schena attributed the growth to increased customer demand for the Sunnyvale, Calif.-based company's microarray products. During the quarter, Arrayit shipped three NanoPrint microarray printers, five SpotBot microarray printers, and a Colorimetric microarray platform, Schena said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.